You are here

Canntab Therapeutics Limited

Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
PILL
CSE Index: 
No
Currency: 
CAD

Canntab Therapeutics Limited is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. Canntab has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use. Simply put, Canntab's mission is to put the "Medical" into medicinal cannabis.

Canntab Therapeutics Limited (PILL)

(%)

*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.

Company Info

Address
1 Adelaide St. East, Suite 801
Toronto, ON M5C 2V9
Canada
Phone
(647) 209-3279
Email
info@canntab.ca
Website
https://canntab.ca
Listing date
Thursday, April 21, 2011
Transfer Agent
Capital Transfer Agency

SEDAR Information

Filing Type Any News Releases Material Change Report Management's Discussion & Analysis Financial Statements
Timeframe 1 week1 month3 month6 month1 yearAll Time

Company Info

Address
1 Adelaide St. East, Suite 801
Toronto, ON M5C 2V9
Canada
Phone
(647) 209-3279
Email
info@canntab.ca
Website
https://canntab.ca
Listing date
Thursday, April 21, 2011
Transfer Agent
Capital Transfer Agency

Capitalization

Issued & Outstanding: 
38909159
Reserved for Issuance: 
16510036

Bulletins

14/06/2024

2024-0613 - Delist - Canntab Therapeutics Limited (PILL)

le 14 juin/June 2024

The common shares of Canntab Therapeutics Limited will be delisted from the CSE at market close today, June 14, 2024.

Canntab Therapeutics is currently suspended. See bulletin 2023-1008.

___________________________